Related Experiment Video
Updated: May 29, 2025

05:44
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
1.3K
Disease Burden in Female Patients With X-Linked Adrenoleukodystrophy
Natalie R Grant1, Yedda Li1,2, Lizbeth De La Rosa Abreu1
1Department of Neurology, Massachusetts General Hospital, Boston.
Neurology
|February 7, 2025
Summary
Female patients with X-linked adrenoleukodystrophy (ALD) experience significant neurological symptoms, mental health issues, and healthcare access barriers. Their disease course is often poorly defined, leading to delayed diagnosis and reduced quality of life.
Area of Science:
- Neuroscience
- Genetics
- Endocrinology
Background:
- X-linked adrenoleukodystrophy (ALD) is a neurodegenerative disorder primarily affecting males.
- The disease course and symptom burden in adult female ALD patients are not well-defined.
Purpose of the Study:
- To characterize the disease burden in adult female individuals with ALD.
- To identify barriers to healthcare access and quality of life impacts for this population.
Main Methods:
- Retrospective chart review and prospective telephone interviews were conducted.
- Data on symptoms, interventions, injuries, comorbidities, and quality of life were collected from 127 female ALD patients.
- A comparison cohort of 82 adult male ALD patients was included.
Main Results:
- 91% of female patients reported neurological symptoms, including urinary issues (74%), walking difficulties (66%), and spasticity (65%).
- Mental health symptoms were reported by 64% of females, with 55% experiencing falls and 43% reporting fractures.
- Female patients were diagnosed later than males and faced challenges in healthcare access, with 90% reporting difficulties and 86% experiencing reduced quality of life.
Conclusions:
- Female individuals with ALD experience a significant disease burden from myelopathy, neuropathy, and mental health issues.
- Barriers in healthcare access and complications like injuries exacerbate the disease impact.
- Delayed diagnosis and misdiagnosis are common challenges for female ALD patients.
More Related Videos
Related Concept Videos
Sex-linked Disorders
100.0K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
100.0K
X-linked Traits
53.0K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
53.0K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Pedigree Analysis
83.7K
Overview
83.7K
Alzheimer's Disease: Overview
432
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
432

